methotrexate has been researched along with Plasmablastic Diffuse Large B-cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Annessi, V; Ascani, S; De Marco, L; Manzini, L; Martiniani, R; Martino, G; Parente, P; Sanguedolce, F; Zanelli, M; Zizzo, M | 1 |
| Tabata, C; Tabata, R; Takei, Y; Uesugi, H | 1 |
| Alpdogan, O; Gong, J; Palmisiano, N; Rhoades, R | 1 |
3 other study(ies) available for methotrexate and Plasmablastic Diffuse Large B-cell Lymphoma
| Article | Year |
|---|---|
Oral plasmablastic lymphoma: A case report.
Topics: Abscess; Adult; Aftercare; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Edema; HIV Infections; HIV Seropositivity; HIV-1; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mouth; Plasma Cells; Plasmablastic Lymphoma; Treatment Outcome | 2020 |
Highly aggressive plasmablastic neoplasms in patients with rheumatoid arthritis treated with methotrexate.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Fatal Outcome; Female; Humans; Methotrexate; Multiple Myeloma; Plasmablastic Lymphoma | 2019 |
Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
Topics: Adult; Antimetabolites, Antineoplastic; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Herpesvirus 4, Human; HIV; HIV Infections; Humans; Male; Methotrexate; Plasmablastic Lymphoma; Rare Diseases; Sarcoma, Kaposi; Treatment Outcome | 2019 |